Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 164 active Myelodysplastic Syndrome trials
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Study Type: Interventional Phase 1
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Study Type: Interventional Phase 1
Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF
Study Type: Interventional
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies
Study Type: Interventional Phase 1
Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
Study Type: Interventional Phase 2
Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia
Study Type: Interventional Phase 1
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
Study Type: Interventional Phase 2
Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
Study Type: Interventional Phase 2
There are 164 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now